Actively Recruiting

Age: 70Years +
All Genders
NCT06717178

Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China

Led by RenJi Hospital · Updated on 2025-04-02

322

Participants Needed

2

Research Sites

53 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this observational study is to learn about the impact of chemotherapy-related toxicity on older cancer patients in China. The main question it aims to answer is: Does the Cancer and Aging Research Group (CARG) chemotherapy toxicity risk score predict chemotherapy-related toxicity in Chinese cancer patients over age 70? Participants over age 70 on systemic chemotherapy will answer questions listed in the CARG chemotherapy toxicity risk tool.

CONDITIONS

Official Title

Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China

Who Can Participate

Age: 70Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 70 years or older
  • Confirmed diagnosis of solid tumor at any stage
  • ECOG performance status score of 0 to 2
  • Admission to hospital for a new chemotherapy regimen (initial or change)
  • Ability to read and write, or communicate in Chinese
  • Ability to provide informed consent
Not Eligible

You will not qualify if you...

  • Patients receiving only immunotherapy and/or targeted therapy
  • Patients with blood cancers (hematologic malignancy)
  • Patients with severe infections such as sepsis or severe respiratory, urinary, or abdominal infections
  • Patients with severe heart, liver, or kidney dysfunction or failure

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Henan Cancer Hospital

Zhengzhou, Henan, China, 450003

Actively Recruiting

2

Renji Hospital

Shanghai, Shanghai Municipality, China, 200127

Actively Recruiting

Loading map...

Research Team

L

Lirong Yang

CONTACT

X

Xiaoxia Qiu

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here